Loading
PDBj
メニューPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

5D6P

Crystal structure of the ATP binding domain of S. aureus GyrB complexed with a ligand

5D6P の概要
エントリーDOI10.2210/pdb5d6p/pdb
関連するPDBエントリー5CPH 5CTU 5CTW 5CTX 5CTY 5D6Q
分子名称DNA gyrase subunit B, 1-ethyl-3-[4-(hydroxymethyl)-5-(1H-pyrrol-2-yl)-1,3-thiazol-2-yl]urea, (4S)-2-METHYL-2,4-PENTANEDIOL, ... (5 entities in total)
機能のキーワードdna gyrase, gyrb, ligand, structure-based design, isomerase-isomerase inhibitor complex, isomerase/isomerase inhibitor
由来する生物種Staphylococcus aureus
細胞内の位置Cytoplasm : P0A0K8
タンパク質・核酸の鎖数2
化学式量合計48842.46
構造登録者
主引用文献Zhang, J.,Yang, Q.,Cross, J.B.,Romero, J.A.,Poutsiaka, K.M.,Epie, F.,Bevan, D.,Wang, B.,Zhang, Y.,Chavan, A.,Zhang, X.,Moy, T.,Daniel, A.,Nguyen, K.,Chamberlain, B.,Carter, N.,Shotwell, J.,Silverman, J.,Metcalf, C.A.,Ryan, D.,Lippa, B.,Dolle, R.E.
Discovery of Azaindole Ureas as a Novel Class of Bacterial Gyrase B Inhibitors.
J.Med.Chem., 58:8503-8512, 2015
Cited by
PubMed Abstract: The emergence and spread of multidrug resistant bacteria are widely believed to endanger human health. New drug targets and lead compounds exempt from cross-resistance with existing drugs are urgently needed. We report on the discovery of azaindole ureas as a novel class of bacterial gyrase B inhibitors and detail the story of their evolution from a de novo design hit based on structure-based drug design. These inhibitors show potent minimum inhibitory concentrations against fluoroquinolone resistant MRSA and other Gram-positive bacteria.
PubMed: 26460684
DOI: 10.1021/acs.jmedchem.5b00961
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.05 Å)
構造検証レポート
Validation report summary of 5d6p
検証レポート(詳細版)ダウンロードをダウンロード

226707

件を2024-10-30に公開中

PDB statisticsPDBj update infoContact PDBjnumon